Identification of a single MPV17 nonsense-associated altered splice variant in 24 South African infants with mitochondrial neurohepatopathy.
Surita MeldauR J De LacyG T M RiordanE A GoddardK PillayK J FieggenA D MaraisG F Van der WattPublished in: Clinical genetics (2018)
MPV17-related mitochondrial neurohepatopathy is a rare genetic disorder worldwide. We report on a novel pathogenic variant in the MPV17 gene in 24 unrelated neurohepatopathic infants of non-consanguineous Black South African heritage. Exome sequencing identified homozygosity for a c.106C>T nonsense variant in exon 3 of the human MPV17 gene in 2 unrelated index patients. mRNA analysis revealed transcripts both with and without exon 3, indicating both reduced splice efficiency and premature termination as mechanisms for disease. Carrier frequency in this population was found to be 1 in 68 (95% CI; 1/122-1/38) with an estimated newborn incidence of 1 in 18 496 (95% CI; 1/59 536-1/5776). Affected infants all presented with infantile onset neurohepatopathy with none surviving beyond infancy. This description of a relatively common pathogenic variant underlying a previously uncharacterized severe neurohepatopathy in South Africa will engender increased awareness, earlier diagnosis and possibly improve outcome if preventative or specific therapeutic options can be found.
Keyphrases
- copy number
- south africa
- genome wide
- oxidative stress
- end stage renal disease
- endothelial cells
- ejection fraction
- newly diagnosed
- single cell
- risk factors
- cord blood
- prognostic factors
- peritoneal dialysis
- early onset
- genome wide identification
- hepatitis c virus
- body mass index
- drug induced
- binding protein
- physical activity